Trials / Completed
CompletedNCT00636649
Escitalopram Treatment of Night Eating Syndrome
Escitalopram Treatment of Night Eating Syndrome: a Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Night-Eating Syndrome (NES) is an eating disorder characterised by excessive eating at night, sleep disturbance and morning anorexia. This 12-week study examines the effect of escitalopram on symptoms of NES.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Escitalopram | 10-20 mg |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2010-08-01
- Completion
- 2011-07-01
- First posted
- 2008-03-14
- Last updated
- 2016-06-29
- Results posted
- 2013-05-06
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00636649. Inclusion in this directory is not an endorsement.